UT Transplant Center Faculty
William Kenneth Washburn, MD
Professor of Surgery
Valero Distinguished Chair, Transplant Center
Board Certifications: American Board of Surgery
MD, University of Pittsburgh, PA
General Surgery training, Tufts-New England Medical Center, Boston, MA
Fellowship, Multi-Organ Transplantation and Hepatobiliary Surgery, Harvard-New England Deaconess Hospital
Research interests: established and new pharmacologic agents, outcomes, organ allocation
Clinical interests: adult and pediatric liver and kidney transplant, complex liver and pancreatic surgery
Klintmalm GB, Davis GL, Teperman L, Netto GJ, Washburn K, Rudich SM, Pomfret EA, Vargas HE, Brown R, Eckhoff D, Pruett TL, Roberts J, Mulligan DC, Charlton MR, Heffron TG, Ham JM, Douglas DD, Sher L, Baliga PK, Kinkhabwala M, Koneru B, Abecassis M, Millis M, Jennings LW, Fasola CG, Washburn WK. A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C. Liver Transpl 2011 Dec;17(12):1394-1403.
Washburn K, Pomfret E, Roberts J. Liver allocation and distribution: possible next steps. Liver Transpl 2011 Sep;17(9):1005-1012.
Washburn K, Halff G, Washburn WK. Hepatocellular carcinoma and liver transplantation. Curr Opin Organ Transplant 2011 Jun;16(3):297-300.
Sharkey FE, Lytvak I, Prihoda TJ, Speeg KV, Washburn WK, Halff GA. High-grade microsteatosis and delay in hepatic function after orthotopic liver transplantation. Hum Pathol 2011 Mar
Wang Y, Speeg KV, Washburn WK, Halff G. Sirolimus plus sorafenib in treating HCC recurrence after liver transplantation: A case report. World J Gastroenterol 2010 Nov;16(43):5518-5522.
Guiteau JJ, Cotton RT, Washburn WK, Harper A, O'Mahony CA, Sebastian A, Cheng S, Klintmalm G, Ghobrial M, Halff G, Mieles L, Goss J. An early regional experience with expansion of Milan Criteria for liver transplant recipients. Am J Transplant 2010 Sep;10(9):2092-2098.
Washburn K, Edwards E, Harper A, Freeman R. Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system. Am J Transplant 2010 Jul;10(7):1643-1648.
Pomfret EA, Washburn K, Wald C, Nalesnik MA, Douglas D, Russo M, Roberts J, Reich DJ, Schwartz ME, Mieles L, Lee FT, Florman S, Yao F, Harper A, Edwards E, Freeman R, Lake J, Washburn WK. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl 2010 Mar;16(3):262-278.
Washburn K. Model for End Stage Liver Disease and hepatocellular carcinoma: a moving target. Transplant Rev (Orlando) 2010 Jan;24(1):11-17.
Washburn WK, Meo NA, Halff GA, Roberts JP, Feng S. Factors influencing liver transplant length of stay at two large-volume transplant centers. Liver Transpl 2009 Oct;15(11):1570-1578.
Berg CL, Steffick DE, Edwards EB, Heimbach JK, Magee JC, Washburn WK, Mazariegos GV. Liver and intestine transplantation in the United States 1998-2007. Am J Transplant 2009 Apr;9(4 Pt):907-931.
Sharron JA, Esterl RM, Washburn WK, Abrahamian GA. Surgical Surgical Treatment of an Extrarenal Pseudoaneurysm After Kidney Transplantation. Vasc Endovascular Surg 2009 Feb
Barshes NR, Becker NS, Washburn WK, Halff GA, Aloia TA, Goss JA. Geographic disparities in deceased donor liver transplantation within a single UNOS region. Liver Transplantation 13:747-751, 2007.
Humar A, Washburn K, Freeman R, Paya CV, Mouas H, Alecock E, Razonable RR. An assessment of interations between hepatitis C virus and herpesvirus reactivation in liver transplant recipients using molecular surveillance. Liver Transplantation 13:1422-1427, 2007.
Baskin-Bey ES, Washburn WK, Feng S, Oltersdorf T, Shapiro D, Huyghe MiRA, Burgart L, Garrity-Park M, van Vilsteren FGI, Oliver LK, Rosen CB, Gores GJ. Clinical Trial of the Pan-Caspase Inhibitor, IDN-6556, in Human Liver Preservation Injury American J Transplantation 2007 Jan; 7 (1), 218-225.
Washburn WK, Pollock BH, Nichols L, Speeg KV, Halff GA. Impact of Recipient MELD score on Resource Utilization. American J Transplantation 2006; 6:2449-2454.
Mejia A, BarshesN, Halff G, Goss J, Washburn WK. Use of Split Liver Alografts does not Impair Pediatric Recipient Growth Liver Transplantation 2007; 13:145-148.
Wiltshire H, Hirankarn S, Farrell C, Paya C, Pescovitz MD, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, Freeman R, Heaton N, and the Valganciclovir Solid Organ Transplant Study Group. Pharmacodynamics of Oral Ganciclovir and Valganciclovir in Solid Organ Transplant Recipients.
Pharmacokinetic Profile of Ganciclovir after its Oral Administration and from its Prodrug, Valganciclovir, in Solid Organ Transplant Recipients Clin Pharmacokinet 2005; 44(5): 495-507.
Pollack MS, Speeg KV, Callander NS, Freytes CO, Espinoza AA, Esterl RM, Abrahamian GA, Washburn WK, and Halff GA. Late-Onset Graft-Versus-Host Disease in a Liver Transplant Recipient Documented by Chimerism Analysis Human Immunology 66, 28-31 (2005), American Society for Histocompatibility and Immunogenetics, 2005. Published by Elsevier Inc.
Wiltshire H, Paya C, Pescovitz M, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, Freeman R, Heaton N, Zuideveld KP, and the Valganciclovir Solid Organ Transplant Study Group. Pharmacodynamics of Oral Ganciclovir and Valganciclovir in Solid Organ Transplant Recipients. Transplantation, Volume 79, Number 11, June 16, 2005.
Washburn WK, Teperman LW, Heffron TG, Douglas DD, Gay S, Katz E, Klintmalm GBG. A Novel Three-Dose Regimen oof Daclizumab in Liver Transplant Recipients with Hepatitis C: A Pharmakokinetic and Pharmacodynamic Study. Liver Transpl 12:585-591, 2006. Published online in Wiley InterScience; 2006 American Association for the Study of Liver Diseases.
Washburn K, Harper A, Klintmalm G, Goss J, Halff G Regional Sharing for Adult Status 1 Candidates: Reduction in Waitlist Mortality 2006 American Association for the Study of Liver Diseases; Published onlnine in Wiley InterScience.
Woodle ES, Vincenti F, Lorber MI, Gritsch HA, Hricik D, Washburn K, Matas AJ, Gallichio M, Neylan J. A Multicenter Pilot Study of Early (4-Day) Steroid Cessation in Renal Transplant Recipients Under Simulect, Tacrolimus and Sirolimus. American Journal of Transplantation 2005; 5: 157-166.
Lee TC, Barshes NR, Washburn WK, Halff GA, Carter BA, Karpen SJ, Bristow LJ, Scott JD, Goss JA. Split-Liver Transplantation Using the Left Lateral Segment: A Collaborative Sharing Experience Between Two Distant Centers. American Journal of Transplantation 2005; 5: 1646-1651.
Biosketch: Dr. Washburn completed his Medical School Education at the University of Pittsburgh, PA and did his General Surgery Residency at Tufts-New England Medical Center in Boston, MA. In 1995, Dr. Washburn completed a fellowship in Multi-Organ Transplantation and Hepatobiliary and Pancreatic Surgery. After completion of his military service, Dr. Washburn joined the University of Texas Health Science Center in 1997.
Dr. Washburn is currently the Surgical Director of the Liver Transplant Program at UTHSCSA. In addition to his expertise in Organ Transplantation, Dr. Washburn has 20 years of experience in Hepatobiliary and Pancreatic Surgery. He specializes in complex pancreatic surgery and all open and laparoscopic liver resections. Along with Drs. Halff and Almeda, the team can offer left trisegmentectomies and central liver resections, surgeries that are more complicated than traditional liver operations. This offers patients many options when dealing with primary and secondary liver cancer. As transplant physicians, Dr. Washburn and the other surgeons frequently operate on high-risk patients with liver cirrhosis, and even offer surgery for portal hypertension.
2012, San Antonio Magazine, 'Best Doctors in America'®
2010, San Antonio Magazine 'Best Doctors'
Fellow, American College of Surgeons
American Society of Transplant Surgeons
American Association for the Study of Liver Disease
Bexar County Medical Society
Texas Medical Assocoation